BACKGROUND: Coffee has been reported to lower levels of estrogen and insulin, two hormones implicated in endometrial carcinogenesis, but prospective data on the relation between coffee consumption and risk of endometrial cancer are limited. METHODS: We prospectively assessed coffee consumption in relation to endometrial cancer risk in the Nurses' Health Study (NHS) with 67,470 female participants aged 34 to 59 in 1980. Cumulative average coffee intake was calculated with all available questionnaires to assess long-term effects. Cox regression models were used to calculate incidence rate ratios (RR), controlling for other risk factors. RESULTS: Fewer than 4 cups of coffee per day were not associated with endometrial cancer risk. However, women who consumed 4 or more cups of coffee had 25% lower risk of endometrial cancer than those who consumed less than 1 cup per day (multivariable RR = 0.75; 95% CI = 0.57-0.97; P(trend) = 0.02). We found the similar association with caffeinated coffee consumption (RR for ≥4 vs. <1 cup/d = 0.70; 95% CI = 0.51-0.95). For decaffeinated coffee consumption, a suggestive inverse association was found among women who consumed 2 or more cups per day versus <1 cup/mo. Tea consumption was not associated with endometrial cancer risk. CONCLUSIONS: These prospective data suggest that four or more cups of coffee per day are associated with a lower risk of endometrial cancer. IMPACT: Drinking of coffee, given its widespread consumption, might be an additional strategy to reduce endometrial cancer risk. However, addition of substantial sugar and cream to coffee could offset any potential benefits.
BACKGROUND: Coffee has been reported to lower levels of estrogen and insulin, two hormones implicated in endometrial carcinogenesis, but prospective data on the relation between coffee consumption and risk of endometrial cancer are limited. METHODS: We prospectively assessed coffee consumption in relation to endometrial cancer risk in the Nurses' Health Study (NHS) with 67,470 female participants aged 34 to 59 in 1980. Cumulative average coffee intake was calculated with all available questionnaires to assess long-term effects. Cox regression models were used to calculate incidence rate ratios (RR), controlling for other risk factors. RESULTS: Fewer than 4 cups of coffee per day were not associated with endometrial cancer risk. However, women who consumed 4 or more cups of coffee had 25% lower risk of endometrial cancer than those who consumed less than 1 cup per day (multivariable RR = 0.75; 95% CI = 0.57-0.97; P(trend) = 0.02). We found the similar association with caffeinated coffee consumption (RR for ≥4 vs. <1 cup/d = 0.70; 95% CI = 0.51-0.95). For decaffeinated coffee consumption, a suggestive inverse association was found among women who consumed 2 or more cups per day versus <1 cup/mo. Tea consumption was not associated with endometrial cancer risk. CONCLUSIONS: These prospective data suggest that four or more cups of coffee per day are associated with a lower risk of endometrial cancer. IMPACT: Drinking of coffee, given its widespread consumption, might be an additional strategy to reduce endometrial cancer risk. However, addition of substantial sugar and cream to coffee could offset any potential benefits.
Authors: M J Stampfer; W C Willett; F E Speizer; D C Dysert; R Lipnick; B Rosner; C H Hennekens Journal: Am J Epidemiol Date: 1984-05 Impact factor: 4.897
Authors: Lena Maria Nilsson; Ingegerd Johansson; Per Lenner; Bernt Lindahl; Bethany Van Guelpen Journal: Cancer Causes Control Date: 2010-05-30 Impact factor: 2.506
Authors: Catherine J Williams; Jessica L Fargnoli; Janice J Hwang; Rob M van Dam; George L Blackburn; Frank B Hu; Christos S Mantzoros Journal: Diabetes Care Date: 2007-12-10 Impact factor: 19.112
Authors: Annekatrin Lukanova; Anne Zeleniuch-Jacquotte; Eva Lundin; Andrea Micheli; Alan A Arslan; Sabina Rinaldi; Paola Muti; Per Lenner; Karen L Koenig; Carine Biessy; Vittorio Krogh; Elio Riboli; Roy E Shore; Par Stattin; Franco Berrino; Göran Hallmans; Paolo Toniolo; Rudolf Kaaks Journal: Int J Cancer Date: 2004-01-10 Impact factor: 7.396
Authors: Annekatrin Lukanova; Eva Lundin; Andrea Micheli; Alan Arslan; Pietro Ferrari; Sabina Rinaldi; Vittorio Krogh; Per Lenner; Roy E Shore; Carine Biessy; Paola Muti; Elio Riboli; Karen L Koenig; Mortimer Levitz; Pär Stattin; Franco Berrino; Göran Hallmans; Rudolf Kaaks; Paolo Toniolo; Anne Zeleniuch-Jacquotte Journal: Int J Cancer Date: 2004-01-20 Impact factor: 7.396
Authors: Melissa A Merritt; Ioanna Tzoulaki; Shelley S Tworoger; Immaculata De Vivo; Susan E Hankinson; Judy Fernandes; Konstantinos K Tsilidis; Elisabete Weiderpass; Anne Tjønneland; Kristina E N Petersen; Christina C Dahm; Kim Overvad; Laure Dossus; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Renée T Fortner; Rudolf Kaaks; Krasimira Aleksandrova; Heiner Boeing; Antonia Trichopoulou; Christina Bamia; Dimitrios Trichopoulos; Domenico Palli; Sara Grioni; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H Bas Bueno-de-Mesquita; N Charlotte Onland-Moret; Petra H Peeters; Inger T Gram; Guri Skeie; J Ramón Quirós; Eric J Duell; María-José Sánchez; D Salmerón; Aurelio Barricarte; Saioa Chamosa; Ulrica Ericson; Emily Sonestedt; Lena Maria Nilsson; Annika Idahl; Kay-Tee Khaw; Nicholas Wareham; Ruth C Travis; Sabina Rinaldi; Isabelle Romieu; Chirag J Patel; Elio Riboli; Marc J Gunter Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-02 Impact factor: 4.254
Authors: Marcelle M Dougan; Susan E Hankinson; Immaculata De Vivo; Shelley S Tworoger; Robert J Glynn; Karin B Michels Journal: Int J Cancer Date: 2015-02-05 Impact factor: 7.396
Authors: Maki Inoue-Choi; Kim Robien; Andrea Mariani; James R Cerhan; Kristin E Anderson Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-11-22 Impact factor: 4.254
Authors: S Uccella; A Mariani; A H Wang; R A Vierkant; W A Cliby; K Robien; K E Anderson; J R Cerhan Journal: Br J Cancer Date: 2013-09-10 Impact factor: 7.640